Loading...

Dan Kaufman

Title(s)Professor, Medicine
SchoolHealth Sciences
Phone858-822-1777
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
    NIH/NCI U01CA217885Sep 12, 2017 - Jul 31, 2022
    Role: Co-Principal Investigator
    Blocking NK cell shedding of CD16a to increase cancer cell killing
    NIH/NCI R01CA203348Jan 1, 2016 - Dec 31, 2020
    Role: Principal Investigator
    Stem Cell Biology Training Program
    NIH/NIGMS T32GM113846Jul 1, 2015 - Jun 30, 2020
    Role: Co-Principal Investigator
    Osteogenic Repair from Human Pluripotent Stem Cells
    NIH/NIDCR R01DE022556Jul 1, 2011 - Jun 30, 2016
    Role: Principal Investigator
    Stem Cell Biology Training Program
    NIH/NICHD T32HD060536Aug 15, 2010 - Jul 31, 2015
    Role: Principal Investigator
    Midwestern Progenitor Cell Consortium
    NIH/NHLBI U01HL100407Sep 30, 2009 - Jun 30, 2016
    Role: Co-Principal Investigator
    Hematopoietic Precursor Development from Human Embryonic Stem (ES) Cells
    NIH/NHLBI R01HL077923Apr 1, 2006 - Mar 31, 2012
    Role: Principal Investigator
    In Vivo Potential of Human ES Cell-Derived Blood Cells
    NIH/NHLBI R21HL072000Sep 30, 2002 - Aug 31, 2005
    Role: Principal Investigator
    Stem Cell Therapy for Myocardial Repair
    NIH/NHLBI R01HL067828Aug 24, 2001 - Mar 31, 2015
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bernareggi D, Pouyanfard S, Kaufman DS. Development of innate immune cells from human pluripotent stem cells. Exp Hematol. 2019 Mar; 71:13-23. PMID: 30611869.
      View in: PubMed
    2. Zhu H, Kaufman DS. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells. Methods Mol Biol. 2019; 2048:107-119. PMID: 31396935.
      View in: PubMed
    3. Snyder KM, Hullsiek R, Mishra HK, Mendez DC, Li Y, Rogich A, Kaufman DS, Wu J, Walcheck B. Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells. Front Immunol. 2018; 9:2873. PMID: 30574146.
      View in: PubMed
    4. Saetersmoen ML, Hammer Q, Valamehr B, Kaufman DS, Malmberg KJ. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells. Semin Immunopathol. 2019 01; 41(1):59-68. PMID: 30361801.
      View in: PubMed
    5. Angelos MG, Kaufman DS. Advances in the role of the aryl hydrocarbon receptor to regulate early hematopoietic development. Curr Opin Hematol. 2018 07; 25(4):273-278. PMID: 29697485.
      View in: PubMed
    6. Li Y, Hermanson DL, Moriarity BS, Kaufman DS. Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity. Cell Stem Cell. 2018 Aug 02; 23(2):181-192.e5. PMID: 30082067.
      View in: PubMed
    7. Marya NB, Jawaid S, Foley A, Han S, Patel K, Maranda L, Kaufman D, Bhattacharya K, Marshall C, Tennyson J, Cave DR. A randomized controlled trial comparing efficacy of early video capsule endoscopy with standard of care in the approach to nonhematemesis GI bleeding (with videos). Gastrointest Endosc. 2019 01; 89(1):33-43.e4. PMID: 29935143.
      View in: PubMed
    8. Zhu H, Lai YS, Li Y, Blum RH, Kaufman DS. Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy. Stem Cells. 2018 02; 36(2):134-145. PMID: 29235195.
      View in: PubMed
    9. Angelos MG, Abrahante JE, Blum RH, Kaufman DS. Single Cell Resolution of Human Hematoendothelial Cells Defines Transcriptional Signatures of Hemogenic Endothelium. Stem Cells. 2018 02; 36(2):206-217. PMID: 29139170.
      View in: PubMed
    10. Angelos MG, Ruh PN, Webber BR, Blum RH, Ryan CD, Bendzick L, Shim S, Yingst AM, Tufa DM, Verneris MR, Kaufman DS. Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells. Blood. 2017 06 29; 129(26):3428-3439. PMID: 28533309.
      View in: PubMed
    11. Kidwai F, Edwards J, Zou L, Kaufman DS. Fibrinogen Induces RUNX2 Activity and Osteogenic Development from Human Pluripotent Stem Cells. Stem Cells. 2016 08; 34(8):2079-89. PMID: 27331788.
      View in: PubMed
    12. Zou L, Chen Q, Quanbeck Z, Bechtold JE, Kaufman DS. Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells. Sci Rep. 2016 Mar 16; 6:22868. PMID: 26980556; PMCID: PMC4793227.
    13. Hermanson DL, Bendzick L, Kaufman DS. Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer. Methods Mol Biol. 2016; 1441:277-84. PMID: 27177674.
      View in: PubMed
    14. Hermanson DL, Bendzick L, Pribyl L, McCullar V, Vogel RI, Miller JS, Geller MA, Kaufman DS. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer. Stem Cells. 2016 Jan; 34(1):93-101. PMID: 26503833; PMCID: PMC4713309 [Available on 01/01/17].
    15. Angelos MG, Kaufman DS. Pluripotent stem cell applications for regenerative medicine. Curr Opin Organ Transplant. 2015 Dec; 20(6):663-70. PMID: 26536430; PMCID: PMC4635470 [Available on 12/01/16].
    16. Song W, Kaufman DS, Shen W. Efficient generation of endothelial cells from human pluripotent stem cells and characterization of their functional properties. J Biomed Mater Res A. 2016 03; 104(3):678-687. PMID: 26519950.
      View in: PubMed
    17. Li LB, Ma C, Awong G, Kennedy M, Gornalusse G, Keller G, Kaufman DS, Russell DW. Silent IL2RG Gene Editing in Human Pluripotent Stem Cells. Mol Ther. 2016 Mar; 24(3):582-91. PMID: 26444081; PMCID: PMC4786911 [Available on 03/01/17].
    18. Hermanson DL, Kaufman DS. Utilizing chimeric antigen receptors to direct natural killer cell activity. Front Immunol. 2015; 6:195. PMID: 25972867; PMCID: PMC4412125.
    19. Ferrell PI, Xi J, Ma C, Adlakha M, Kaufman DS. The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells. Stem Cells. 2015 Apr; 33(4):1130-41. PMID: 25546363; PMCID: PMC4751882.
    20. Jing Y, Ni Z, Wu J, Higgins L, Markowski TW, Kaufman DS, Walcheck B. Identification of an ADAM17 cleavage region in human CD16 (Fc?RIII) and the engineering of a non-cleavable version of the receptor in NK cells. PLoS One. 2015; 10(3):e0121788. PMID: 25816339; PMCID: PMC4376770.
    21. Zou L, Kidwai FK, Kopher RA, Motl J, Kellum CA, Westendorf JJ, Kaufman DS. Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells. Stem Cell Reports. 2015 Feb 10; 4(2):190-8. PMID: 25680477; PMCID: PMC4325195.
    22. Ye L, Chang YH, Xiong Q, Zhang P, Zhang L, Somasundaram P, Lepley M, Swingen C, Su L, Wendel JS, Guo J, Jang A, Rosenbush D, Greder L, Dutton JR, Zhang J, Kamp TJ, Kaufman DS, Ge Y, Zhang J. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 2014 Dec 04; 15(6):750-61. PMID: 25479750; PMCID: PMC4275050.
    23. Ni Z, Knorr DA, Bendzick L, Allred J, Kaufman DS. Expression of chimeric receptor CD4? by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo. Stem Cells. 2014 Apr; 32(4):1021-31. PMID: 24307574; PMCID: PMC3960346.
    24. Ferrell PI, Hexum MK, Kopher RA, Lepley MA, Gussiaas A, Kaufman DS. Functional assessment of hematopoietic niche cells derived from human embryonic stem cells. Stem Cells Dev. 2014 Jun 15; 23(12):1355-63. PMID: 24517837; PMCID: PMC4046207.
    25. Geller MA, Knorr DA, Hermanson DA, Pribyl L, Bendzick L, McCullar V, Miller JS, Kaufman DS. Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model. Cytotherapy. 2013 Oct; 15(10):1297-306. PMID: 23993303; PMCID: PMC3775496.
    26. Ran D, Lam K, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, Ye Z, Yan M, Cheng L, Kaufman DS, Zhang DE. Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells. Blood. 2013 Jun 27; 121(26):5252-3. PMID: 23813938.
      View in: PubMed
    27. Bock AM, Knorr D, Kaufman DS. Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs). J Vis Exp. 2013 Apr 23; (74):e50337. PMID: 23644738; PMCID: PMC3667548.
    28. Vallera DA, Zhang B, Gleason MK, Oh S, Weiner LM, Kaufman DS, McCullar V, Miller JS, Verneris MR. Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells. Cancer Biother Radiopharm. 2013 May; 28(4):274-82. PMID: 23611188; PMCID: PMC4209492.
    29. Knorr DA, Bock A, Brentjens RJ, Kaufman DS. Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy. Stem Cells Dev. 2013 Jul 01; 22(13):1861-9. PMID: 23421330; PMCID: PMC3685314.
    30. Knorr DA, Ni Z, Hermanson D, Hexum MK, Bendzick L, Cooper LJ, Lee DA, Kaufman DS. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Transl Med. 2013 Apr; 2(4):274-83. PMID: 23515118; PMCID: PMC3659832.
    31. Kaufman DS. Tu-mor(e) blood cells from human pluripotent stem cells. Blood. 2013 Feb 21; 121(8):1245-6. PMID: 23429981.
      View in: PubMed
    32. Xiong Q, Ye L, Zhang P, Lepley M, Tian J, Li J, Zhang L, Swingen C, Vaughan JT, Kaufman DS, Zhang J. Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation. 2013 Mar 05; 127(9):997-1008. PMID: 23371930; PMCID: PMC3980462.
    33. Ran D, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, Ye Z, Yan M, Cheng L, Kaufman DS, Zhang DE. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood. 2013 Apr 11; 121(15):2882-90. PMID: 23372166; PMCID: PMC3624936.
    34. Simara P, Motl JA, Kaufman DS. Pluripotent stem cells and gene therapy. Transl Res. 2013 Apr; 161(4):284-92. PMID: 23353080.
      View in: PubMed
    35. Ni Z, Knorr DA, Kaufman DS. Hematopoietic and nature killer cell development from human pluripotent stem cells. Methods Mol Biol. 2013; 1029:33-41. PMID: 23756940.
      View in: PubMed
    36. Xiong Q, Ye L, Zhang P, Lepley M, Swingen C, Zhang L, Kaufman DS, Zhang J. Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circ Res. 2012 Aug 03; 111(4):455-68. PMID: 22723295; PMCID: PMC3635674.
    37. Rao M, Ahrlund-Richter L, Kaufman DS. Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities. Stem Cells. 2012 Jan; 30(1):55-60. PMID: 22069231.
      View in: PubMed
    38. Sjeklocha LM, Park CW, Wong PY, Roney MJ, Belcher JD, Kaufman DS, Vercellotti GM, Hebbel RP, Steer CJ. Erythroid-specific expression of ß-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells. PLoS One. 2011; 6(12):e29110. PMID: 22216176; PMCID: PMC3247234.
    39. Waldron NN, Kaufman DS, Oh S, Inde Z, Hexum MK, Ohlfest JR, Vallera DA. Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer. Mol Cancer Ther. 2011 Oct; 10(10):1829-38. PMID: 21862685; PMCID: PMC3191276.
    40. Liu Y, Wang X, Kaufman DS, Shen W. A synthetic substrate to support early mesodermal differentiation of human embryonic stem cells. Biomaterials. 2011 Nov; 32(32):8058-66. PMID: 21821284; PMCID: PMC3189998.
    41. Undale A, Fraser D, Hefferan T, Kopher RA, Herrick J, Evans GL, Li X, Kakar S, Hayes M, Atkinson E, Yaszemski MJ, Kaufman DS, Westendorf JJ, Khosla S. Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow. J Orthop Res. 2011 Dec; 29(12):1804-11. PMID: 21674605; PMCID: PMC3179810.
    42. Solh M, DeFor TE, Weisdorf DJ, Kaufman DS. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant. 2012 Jan; 18(1):106-12. PMID: 21703975.
      View in: PubMed
    43. Xiong Q, Hill KL, Li Q, Suntharalingam P, Mansoor A, Wang X, Jameel MN, Zhang P, Swingen C, Kaufman DS, Zhang J. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells. 2011 Feb; 29(2):367-75. PMID: 21732493; PMCID: PMC3412592.
    44. Hexum MK, Tian X, Kaufman DS. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells. Methods Mol Biol. 2011; 767:433-47. PMID: 21822894.
      View in: PubMed
    45. Gori JL, McIvor RS, Kaufman DS. Methotrexate supports in vivo selection of human embryonic stem cell derived-hematopoietic cells expressing dihydrofolate reductase. Bioeng Bugs. 2010 Nov-Dec; 1(6):434-6. PMID: 21468213; PMCID: PMC3056096.
    46. Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. J Virol. 2011 Jan; 85(1):43-50. PMID: 20962093; PMCID: PMC3014194.
    47. Kaufman DS. HIF hits Wnt in the stem cell niche. Nat Cell Biol. 2010 Oct; 12(10):926-7. PMID: 20885419.
      View in: PubMed
    48. Islam MS, Ni Z, Kaufman DS. Use of human embryonic stem cells to understand hematopoiesis and hematopoietic stem cell niche. Curr Stem Cell Res Ther. 2010 Sep; 5(3):245-50. PMID: 20214557.
      View in: PubMed
    49. Knorr DA, Kaufman DS. Pluripotent stem cell-derived natural killer cells for cancer therapy. Transl Res. 2010 Sep; 156(3):147-54. PMID: 20801411; PMCID: PMC2932648.
    50. Kopher RA, Penchev VR, Islam MS, Hill KL, Khosla S, Kaufman DS. Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells. Bone. 2010 Oct; 47(4):718-28. PMID: 20601304; PMCID: PMC2939152.
    51. Hill KL, Obrtlikova P, Alvarez DF, King JA, Keirstead SA, Allred JR, Kaufman DS. Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol. 2010 Mar; 38(3):246-257.e1. PMID: 20067819; PMCID: PMC2838385.
    52. Tian X, Hexum MK, Penchev VR, Taylor RJ, Shultz LD, Kaufman DS. Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells. Stem Cells. 2009 Nov; 27(11):2675-85. PMID: 19711457; PMCID: PMC2857550.
    53. Gori JL, Tian X, Swanson D, Gunther R, Shultz LD, McIvor RS, Kaufman DS. In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase. Gene Ther. 2010 Feb; 17(2):238-49. PMID: 19829316.
      View in: PubMed
    54. Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood. 2009 Oct 22; 114(17):3513-23. PMID: 19652198; PMCID: PMC2766673.
    55. Tomblyn MB, Arora M, Baker KS, Blazar BR, Brunstein CG, Burns LJ, DeFor TE, Dusenbery KE, Kaufman DS, Kersey JH, MacMillan ML, McGlave PB, Miller JS, Orchard PJ, Slungaard A, Tomblyn MR, Vercellotti GM, Verneris MR, Wagner JE, Weisdorf DJ. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. J Clin Oncol. 2009 Aug 01; 27(22):3634-41. PMID: 19581540; PMCID: PMC2720079.
    56. Woll PS, Grzywacz B, Tian X, Marcus RK, Knorr DA, Verneris MR, Kaufman DS. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood. 2009 Jun 11; 113(24):6094-101. PMID: 19365083; PMCID: PMC2699231.
    57. Hill KL, Kaufman DS. Hematopoietic differentiation of human embryonic stem cells by cocultivation with stromal layers. Curr Protoc Stem Cell Biol. 2008 Sep; Chapter 1:Unit 1F.6. PMID: 18819084.
      View in: PubMed
    58. Martin CH, Woll PS, Ni Z, Zúñiga-Pflücker JC, Kaufman DS. Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood. 2008 Oct 01; 112(7):2730-7. PMID: 18621931; PMCID: PMC2556609.
    59. Tian X, Kaufman DS. Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls. Curr Opin Hematol. 2008 Jul; 15(4):312-8. PMID: 18536568.
      View in: PubMed
    60. Cameron CM, Harding F, Hu WS, Kaufman DS. Activation of hypoxic response in human embryonic stem cell-derived embryoid bodies. Exp Biol Med (Maywood). 2008 Aug; 233(8):1044-57. PMID: 18535160.
      View in: PubMed
    61. Bera TK, Saint Fleur A, Ha D, Yamada M, Lee Y, Lee B, Hahn Y, Kaufman DS, Pera M, Pastan I. Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. Stem Cells Dev. 2008 Apr; 17(2):325-32. PMID: 18447647.
      View in: PubMed
    62. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Wagner JE, Weisdorf DJ. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant. 2008 Mar; 14(3):282-9. PMID: 18275894; PMCID: PMC2674378.
    63. Tian X, Kaufman DS. Hematopoietic development of human embryonic stem cells in culture. Methods Mol Biol. 2008; 430:119-33. PMID: 18370295.
      View in: PubMed
    64. Woll PS, Morris JK, Painschab MS, Marcus RK, Kohn AD, Biechele TL, Moon RT, Kaufman DS. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood. 2008 Jan 01; 111(1):122-31. PMID: 17875805; PMCID: PMC2200802.
    65. Wilber A, Linehan JL, Tian X, Woll PS, Morris JK, Belur LR, McIvor RS, Kaufman DS. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells. 2007 Nov; 25(11):2919-27. PMID: 17673526.
      View in: PubMed
    66. Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood. 2007 Apr 01; 109(7):2688-92. PMID: 17132724.
      View in: PubMed
    67. Cameron CM, Hu WS, Kaufman DS. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng. 2006 Aug 05; 94(5):938-48. PMID: 16547998.
      View in: PubMed
    68. Anderson JS, Bandi S, Kaufman DS, Akkina R. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology. 2006 Apr 19; 3:24. PMID: 16623949; PMCID: PMC1462997.
    69. Tian X, Woll PS, Morris JK, Linehan JL, Kaufman DS. Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells. 2006 May; 24(5):1370-80. PMID: 16456127.
      View in: PubMed
    70. Qiu C, Hanson E, Olivier E, Inada M, Kaufman DS, Gupta S, Bouhassira EE. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol. 2005 Dec; 33(12):1450-8. PMID: 16338487.
      View in: PubMed
    71. Schwartz RE, Linehan JL, Painschab MS, Hu WS, Verfaillie CM, Kaufman DS. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev. 2005 Dec; 14(6):643-55. PMID: 16433619.
      View in: PubMed
    72. Narayan AD, Chase JL, Lewis RL, Tian X, Kaufman DS, Thomson JA, Zanjani ED. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood. 2006 Mar 01; 107(5):2180-3. PMID: 16278307; PMCID: PMC1895718.
    73. Woll PS, Martin CH, Miller JS, Kaufman DS. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol. 2005 Oct 15; 175(8):5095-103. PMID: 16210613.
      View in: PubMed
    74. Martin CH, Kaufman DS. Synergistic use of adult and embryonic stem cells to study human hematopoiesis. Curr Opin Biotechnol. 2005 Oct; 16(5):510-5. PMID: 16095900.
      View in: PubMed
    75. Hematti P, Obrtlikova P, Kaufman DS. Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. Exp Hematol. 2005 Sep; 33(9):980-6. PMID: 16140145.
      View in: PubMed
    76. Tian X, Kaufman DS. Hematopoietic development of human embryonic stem cells in culture. Methods Mol Biol. 2005; 290:149-62. PMID: 15361661.
      View in: PubMed
    77. Tian X, Kaufman DS. Hematopoietic development of human embryonic stem cells in culture. Methods Mol Med. 2005; 105:425-36. PMID: 15492412.
      View in: PubMed
    78. Tian X, Morris JK, Linehan JL, Kaufman DS. Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol. 2004 Oct; 32(10):1000-9. PMID: 15504555.
      View in: PubMed
    79. Lakshmipathy U, Pelacho B, Sudo K, Linehan JL, Coucouvanis E, Kaufman DS, Verfaillie CM. Efficient transfection of embryonic and adult stem cells. Stem Cells. 2004; 22(4):531-43. PMID: 15277699.
      View in: PubMed
    80. Chen D, Lewis RL, Kaufman DS. Mouse and human embryonic stem cell models of hematopoiesis: past, present, and future. Biotechniques. 2003 Dec; 35(6):1253-61. PMID: 14682061.
      View in: PubMed
    81. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood. 2004 Feb 15; 103(4):1325-32. PMID: 14563647.
      View in: PubMed
    82. Kaufman DS, Thomson JA. Human ES cells--haematopoiesis and transplantation strategies. J Anat. 2002 Mar; 200(Pt 3):243-8. PMID: 12033728.
      View in: PubMed
    83. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2001 Sep 11; 98(19):10716-21. PMID: 11535826.
      View in: PubMed
    84. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001; 19(3):193-204. PMID: 11359944.
      View in: PubMed
    85. Kaufman DS. A scientific rationale for human embryonic stem cell research. Yale J Health Policy Law Ethics. 2001; 2(1):109, 177-87. PMID: 12664943.
      View in: PubMed
    86. Kaufman DS, Schoon RA, Robertson MJ, Leibson PJ. Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I. Proc Natl Acad Sci U S A. 1995 Jul 03; 92(14):6484-8. PMID: 7604018.
      View in: PubMed
    87. Kaufman DS, Schoon RA, Leibson PJ. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J Immunol. 1993 Feb 15; 150(4):1429-36. PMID: 8432986.
      View in: PubMed
    88. Kaufman DS, Schoon RA, Leibson PJ. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc Natl Acad Sci U S A. 1992 Sep 01; 89(17):8337-41. PMID: 1325654.
      View in: PubMed